Adult congenital heart disease (ACHD) occurs when you have one or more abnormalities in your heart that were present when you were born. There are a wide variety of congenital heart defects, so you need a team that’s experienced in providing top-notch treatment to care for you. The Ohio State University Wexner Medical Center has a one of the largest adult congenital heart disease programs in the nation, with a team of specialists focused on adult congenital heart disease treatments and research.
Why choose Ohio State for ACHD treatment?
Since completing our first heart transplant in 1986, The Ohio State University Wexner Medical Center has been the only adult heart transplant center in central Ohio. Ohio State Richard M. Ross Heart Hospital is consistently recognized as a leader in heart care and heart surgery in U.S. News & World Report. We focus on the physical, psychological, emotional and social needs of patients with end-stage heart disease, through transplantation to post-transplant care.
Our researchers were among the first in the nation to evaluate the use of cyclosporine, a drug that suppresses the immune system and dramatically improves the success of organ transplantation. Our research teams are currently studying new methods to lengthen the amount of time a heart remains viable for transplantation and are constantly exploring new ways to improve the transplant experience for patients.
We’re the only hospital in central Ohio that partners with Nationwide Children’s Hospital to provide specialized care from birth to adulthood for those with congenital heart disease We provide the resources necessary for the care of adult congenital cardiac patients through the Columbus Ohio Adult Congenital Heart Disease Program.
Ohio State has one of the largest adult congenital heart disease (CHD) programs in the nation dedicated to helping women with congenital heart defects and acquired heart conditions who are, or wish to become, pregnant.